AMD's Ryzen AI Max chips came as a huge surprise at CES 2025. They're basically super-powered versions of the company's Ryzen ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Good morning. Joe Biden takes one final stand to limit AI chip exports. Apple loses its latest plea to keep iPhones in ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Key Takeaways Advanced Micro Devices shares fell Wednesday after a double downgrade by analysts at HSBC to "reduce" from "buy ...

AMD kicks of CES 2025 with a bang: its Ryzen AI Max processor combines discrete-level graphics with powerful AI, all ...

AMD announced its Ryzen AI Max processors at CES, ushering in a new series of AMD -based AI PCs and laptops. The chipmaker ...

Nvidia (NVDA) and AMD (AMD) made headlines on Monday as each chipmaker unveiled their widely anticipated latest artificial ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Minisforum, a leader in innovative compact computing solutions, is thrilled to announce its participation in CES 2025, the ...